Two to tango: GPCR oligomers and GPCR-TRP channel interactions in nociception

The capsaicin receptor: a heat-activated ion channel in the pain pathway

Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. J. (1997) · Nature · doi:10.1038/39807 · Cited by 9,132 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice

Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,612 · see citing works

Molecular mechanisms of nociception

Julius, D., & Basbaum, A. I. (2001) · Nature · doi:10.1038/35093019 · Cited by 2,685 · see citing works

TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents

Bautista, D. M., Jordt, S. E., Nikai, T., Tsuruda, P. R., Read, A. J., Poblete, J., Yamoah, E. N., Basbaum, A. I., & Julius, D. J. (2006) · Cell · doi:10.1016/j.cell.2006.02.023 · Cited by 1,921 · see citing works

TRP Channels

Venkatachalam, K., & Montell, C. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142819 · Cited by 1,915 · see citing works

Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1

Jordt, S., Bautista, D. M., Chuang, H.-H., McKemy, D. D., Zygmunt, P. M., Högestätt, E. D., Meng, I. D., & Julius, D. J. (2004) · Nature · doi:10.1038/nature02282 · Cited by 1,896 · see citing works

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Marzo, V. D., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,610 · see citing works

Goodman and Gilman's The Pharmacological Basis of Therapeutics

FRAUNFELDER, F. T. (1981) · American Journal of Ophthalmology · doi:10.1016/0002-9394(81)90318-4 · Cited by 1,335 · see citing works

Cloning of a Delta Opioid Receptor by Functional Expression

Evans, C. J., Keith, D. E., Morrison, H., Magendzo, K., & Edwards, R. H. (1992) · Science · doi:10.1126/science.1335167 · Cited by 1,206 · see citing works

G-protein-coupled receptor heterodimerization modulates receptor function

Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,169 · see citing works

Stereospecific Binding of the Potent Narcotic Analgesic [ 3 H]Etorphine to Rat-Brain Homogenate

Simon, E. J., Hiller, J. M., & Edelman, I. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.7.1947 · Cited by 1,070 · see citing works

The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.

Kieffer, B. L., Befort, K., Gavériaux‐Ruff, C., & HIRTH, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 994 · see citing works

Nociceptor sensitization in pain pathogenesis

Gold, M. S., & Gebhart, G. F. (2010) · Nature Medicine · doi:10.1038/nm.2235 · Cited by 899 · see citing works

The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept

SZALLASI, A., Cortright, D. N., Blum, C. A., & Eid, S. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2280 · Cited by 884 · see citing works

Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms

von Hehn, C. A., Baron, R., & Woolf, C. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.008 · Cited by 804 · see citing works

A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation

Hébert, T. E., Moffett, S., Morello, J.-P., Loisel, T. P., Bichet, D. G., Barret, C., & Bouvier, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16384 · Cited by 775 · see citing works

Rhodopsin dimers in native disc membranes

Fotiadis, D., Liang, Y., Filipek, S., Saperstein, D. A., Engel, A., & Palczewski, K. (2003) · Nature · doi:10.1038/421127a · Cited by 749 · see citing works

A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein

Whorton, M. R., Bokoch, M. P., Rasmussen, S. G. F., Huang, B., Zare, R. N., Kobilka, B. K., & Sunahara, R. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611448104 · Cited by 671 · see citing works

Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission

Katona, I., Rancz, E. A., Acsády, L., Ledent, C., Mackie, K., Hájos, N., & Freund, T. F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09506.2001 · Cited by 668 · see citing works

Stereospecific Interaction Between Narcotic Analgesics and a Synaptic Plasma Membrane Fraction of Rat Cerebral Cortex

Terenius, L. Y. (1973) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1973.tb01477.x · Cited by 660 · see citing works

Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Augments cAMP Accumulation in Striatal Neurons: Evidence for a GsLinkage to the CB1 Receptor

Glass, M., & Felder, C. C. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05327.1997 · Cited by 634 · see citing works

TRPA1 is required for histamine-independent, Mas-related G protein–coupled receptor–mediated itch

Wilson, S. R., Gerhold, K. A., Bifolck-Fisher, A., Liu, Q., Patel, K., Dong, X., & Bautista, D. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2789 · Cited by 599 · see citing works

Oligomerization of μ- and δ-Opioid Receptors

George, S. R., Fan, T., Xie, Z., Tse, R., Tam, V. C., Varghese, G. K., & O’Dowd, B. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000345200 · Cited by 557 · see citing works

Sensitization of TRPV1 by EP1 and IP Reveals Peripheral Nociceptive Mechanism of Prostaglandins

Moriyama, T., Higashi, T., Togashi, K., Iida, T., Segi‐Nishida, E., Sugimoto, Y., Tominaga, T., Narumiya, S., & Tominaga, M. (2005) · Molecular Pain · doi:10.1186/1744-8069-1-3 · Cited by 551 · see citing works

Opiate Agonists and Antagonists Discriminated by Receptor Binding in Brain

Pert, C. B., Pasternak, G. W., & Snyder, S. H. (1973) · Science · doi:10.1126/science.182.4119.1359 · Cited by 545 · see citing works

Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations

Hájos, N., Katona, I., Naiem, S. S., Mackie, K., Ledent, C. A., Módy, I., & Freund, T. F. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00217.x · Cited by 533 · see citing works

Dimerization of the δ Opioid Receptor:

Cvejic, S., & Devi, L. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26959 · Cited by 489 · see citing works

Fine-tuning of GPCR activity by receptor-interacting proteins

Ritter, S. L., & Hall, R. A. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2803 · Cited by 479 · see citing works

G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology

Milligan, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000497 · Cited by 474 · see citing works

Heterodimerization of mu and delta opioid receptors: A role in opiate synergy.

Gomes, I., Jordan, B. A., Gupta, A., Trapaidze, N., Nagy, V., & Devi, L. A. (2000) · PubMed Central · doi:10.1523/jneurosci.20-22-j0007.2000 · Cited by 471 · see citing works

Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain

Scherrer, G., Imamachi, N., Cao, Y. Q., Contet, C., Mennicken, F., O’Donnell, D., Kieffer, B. L., & Basbaum, A. I. (2009) · Cell · doi:10.1016/j.cell.2009.04.019 · Cited by 463 · see citing works

TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms

Imamachi, N., Park, G. H., Lee, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905605106 · Cited by 451 · see citing works

Cloning and pharmacological characterization of a rat μ opioid receptor

Thompson, R. C., Mansour, A., Akil, H., & Watson, S. J. (1993) · Neuron · doi:10.1016/0896-6273(93)90120-g · Cited by 451 · see citing works

Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation

Bulenger, S., Marullo, S., & Bouvier, M. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.004 · Cited by 450 · see citing works

Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse

Bjarnadóttir, T. K., Gloriam, D. E. I., Hellstrand, S. H., Kristiansson, H., Fredriksson, R., & Schiöth, H. B. (2006) · Genomics · doi:10.1016/j.ygeno.2006.04.001 · Cited by 433 · see citing works

Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.

Abdelhamid, E. E., Sultana, M., Portoghese, P. S., et al. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20227-0 · Cited by 429 · see citing works

Cloning and pharmacological characterization of a rat kappa opioid receptor.

Meng, F., Xie, G. X., Thompson, R. C., Mansour, A., D, A. G. M., Watson, S. J., & Akil, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9954 · Cited by 420 · see citing works

Dimerization of the Extracellular Calcium-sensing Receptor (CaR) on the Cell Surface of CaR-transfected HEK293 Cells

Bai, M., Trivedi, S., & Brown, E. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23605 · Cited by 406 · see citing works

mu opiate receptor: cDNA cloning and expression.

Wang, J. B., Imai, Y., Eppler, C. M., Gregor, P., Spivak, C. E., & Uhl, G. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10230 · Cited by 405 · see citing works

Building a new conceptual framework for receptor heteromers

Ferré, S., Baler, R., Bouvier, M., Caron, M. G., Devi, L. A., Durroux, T., Fuxé, K., George, S. R., Javitch, J. A., Lohse, M. J., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio0309-131 · Cited by 395 · see citing works

Pharmacological and biochemical interactions between opioids and cannabinoids

Manzanares, J., Corchero, J., Romero, J., Fernández‐Ruíz, J., Ramos, J. A., & Fuentes, J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 391 · see citing works

Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance

Prinster, S. C., Hague, C., & Hall, R. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.1 · Cited by 373 · see citing works

Ultrastructural Localization of the CB1 Cannabinoid Receptor in μ-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus

Rodriguez, J. J., Mackie, K., & Pickel, V. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00823.2001 · Cited by 363 · see citing works

Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk?

Kearn, C. S., Blake-Palmer, K. G., Daniel, E., Mackie, K., & Glass, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006882 · Cited by 358 · see citing works

A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers

Waldhoer, M., Fong, J. C., Jones, R. M., Lunzer, M. M., Sharma, S. K., Kostenis, E., Portoghese, P. S., & Whistler, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501112102 · Cited by 351 · see citing works

Oligomerization of opioid receptors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation

Jordan, B. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011384898 · Cited by 328 · see citing works

<i>μ</i> opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis

Rios, C., Gomes, I., & Devi, L. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706757 · Cited by 327 · see citing works

Oxytocin and Vasopressin V1a and V2 Receptors Form Constitutive Homo- and Heterodimers during Biosynthesis

Terrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan‐Cadars, M., Jockers, R., Barberis, C., & Bouvier, M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0222 · Cited by 323 · see citing works

Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting

Salahpour, A., Angers, S., Mercier, J.-F., Lagacé, M., Marullo, S., & Bouvier, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403363200 · Cited by 297 · see citing works

Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series

Daniels, D. J., Lenard, N. R., Etienne, C. L., Law, P., Roerig, S. C., & Portoghese, P. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506627102 · Cited by 297 · see citing works

Structure of the rhodopsin dimer: a working model for G-protein-coupled receptors

Fotiadis, D., Jastrzębska, B., Philippsen, A., Müller, D. J., Palczewski, K., & Engel, A. H. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.03.013 · Cited by 271 · see citing works

Efficient Coupling of Transducin to Monomeric Rhodopsin in a Phospholipid Bilayer

Whorton, M. R., Jastrzębska, B., Park, P. S. ‐., Fotiadis, D., Engel, A. H., Palczewski, K., & Sunahara, R. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703346200 · Cited by 266 · see citing works

Heterodimerization of Somatostatin and Opioid Receptors Cross-modulates Phosphorylation, Internalization, and Desensitization

Pfeiffer, M., Koch, T., Schröder, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110373200 · Cited by 264 · see citing works

Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors

Ghozland, S. G., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01146.2002 · Cited by 263 · see citing works

Striatal Adenosine A2A and Cannabinoid CB1 Receptors Form Functional Heteromeric Complexes that Mediate the Motor Effects of Cannabinoids

Carriba, P., Ortiz, O., Patkar, K. A., Justinová, Z., Stroik, J., Themann, A., Müller, C. E., Woods, A. S., Hope, B. T., Ciruela, F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301375 · Cited by 260 · see citing works

An introduction to the endocannabinoid system: from the early to the latest concepts

PETROCELLIS, L. D., & Marzo, V. D. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.013 · Cited by 249 · see citing works

Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers

Zeng, F., & Wess, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19487 · Cited by 247 · see citing works

Compartment-specific localization of cannabinoid 1 (CB1) and μ-opioid receptors in rat nucleus accumbens

Pickel, V. M., Chan, J., Kash, T. L., Rodrı́guez, J.-J., & Mackie, K. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.015 · Cited by 243 · see citing works

Facilitation of μ-Opioid Receptor Activity by Preventing δ-Opioid Receptor-Mediated Codegradation

He, S.-Q., Zhang, Z., Guan, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.001 · Cited by 235 · see citing works

The G protein‐coupled receptor rhodopsin in the native membrane

Fotiadis, D., Liang, Y., Filipek, S., Saperstein, D. A., Engel, A. H., & Palczewski, K. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00194-2 · Cited by 227 · see citing works

Increased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration

Gupta, A., Mulder, J., Gomes, I., Rozenfeld, R., Bushlin, I., Ong, E. W., Lim, M. P., Maillet, É. L., Junek, M., Cahill, C. M., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2000807 · Cited by 226 · see citing works

Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function

Ellis, J., Pediani, J. D., Canals, M., Milasta, S., & Milligan, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602494200 · Cited by 225 · see citing works

Methods to monitor the quaternary structure of G protein‐coupled receptors

Milligan, G., & Bouvier, M. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04731.x · Cited by 213 · see citing works

Coexpression of δ- and μ-opioid receptors in nociceptive sensory neurons

Wang, H.-B., Zhao, B., Zhong, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008382107 · Cited by 212 · see citing works

Neurokinin-1 Receptor Enhances TRPV1 Activity in Primary Sensory Neurons via PKCε: A Novel Pathway for Heat Hyperalgesia

Zhang, H., Cang, C., Kawasaki, Y., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0496-07.2007 · Cited by 193 · see citing works

From Models to Molecules: Opioid Receptor Dimers, Bivalent Ligands, and Selective Opioid Receptor Probes

Portoghese, P. S. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010158+ · Cited by 188 · see citing works

Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor

Hilairet, S., Bouaboula, M., Carrière, D., Fur, G. L., & Casellas, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212369200 · Cited by 188 · see citing works

Opioids and Their Complicated Receptor Complexes

Jordan, B. A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00143-3 · Cited by 176 · see citing works

Selective Natrexone-Derived Opioid Receptor Antagonists

Takemori, A. E., & Portoghese, P. S. (1992) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.32.040192.001323 · Cited by 176 · see citing works

Functional Interactions between μ Opioid and α2A-Adrenergic Receptors

Jordan, B. A., Gomes, I., Rios, C., Filipovska, J., & Devi, L. A. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1317 · Cited by 173 · see citing works

Activation of TRPV1 Contributes to Morphine Tolerance: Involvement of the Mitogen-Activated Protein Kinase Signaling Pathway

Chen, Y., Geis, C., & Sommer, C. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4170-07.2008 · Cited by 165 · see citing works

Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis

Marcellino, D. J., Carriba, P., Filip, M., Borgkvist, A., Frankowska, M., Bellido-Estévez, I., Tanganelli, S., Müller, C. E., Fisone, G., Lluı́s, C., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.12.011 · Cited by 164 · see citing works

Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer

Wang, D., Sun, X., Bohn, L., & Sadée, W. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010272 · Cited by 160 · see citing works

CB1-cannabinoid and μ-opioid receptor co-localization on postsynaptic target in the rat dorsal horn

Salio, C., Fischer, J., Franzoni, M. F., Mackie, K., Kaneko, T., & Conrath, M. (2001) · Neuroreport · doi:10.1097/00001756-200112040-00017 · Cited by 159 · see citing works

μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis

Hojo, M., Sudo, Y., Ando, Y., Minami, K., Takada, M., Matsubara, T., Kanaide, M., Taniyama, K., Sumikawa, K., & Uezono, Y. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08244fp · Cited by 148 · see citing works

Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example

Wager‐Miller, J., Westenbroek, R. E., & Mackie, K. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00151-2 · Cited by 144 · see citing works

Impaired Nociception and Inflammatory Pain Sensation in Mice Lacking the Prokineticin Receptor PKR1: Focus on Interaction between PKR1 and the Capsaicin Receptor TRPV1 in Pain Behavior

Negri, L., Lattanzi, R., Giannini, E., Colucci, M., Margheriti, F., Melchiorri, P., Vellani, V., Tian, H., Felice, M. D., & Porreca, F. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5403-05.2006 · Cited by 143 · see citing works

Genetic Dissociation of Opiate Tolerance and Physical Dependence in δ-Opioid Receptor-1 and Preproenkephalin Knock-Out Mice

Nitsche, J. F., Schuller, A. G., King, M. A., Zengh, M., Pasternak, G. W., & Pintar, J. E. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10906.2002 · Cited by 134 · see citing works

A Bivalent Ligand (KDN-21) Reveals Spinal δ and κ Opioid Receptors Are Organized as Heterodimers That Give Rise to δ1 and κ2 Phenotypes. Selective Targeting of δ−κ Heterodimers

Bhushan, R. G., Sharma, S. K., Xie, Z., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0342358 · Cited by 131 · see citing works

Narcotic antagonistic potency of bivalent ligands which contain .beta.-naltrexamine. Evidence for simultaneous occupation of proximal recognition sites

Erez, M., Takemori, A. E., & Portoghese, P. S. (1982) · Journal of Medicinal Chemistry · doi:10.1021/jm00349a016 · Cited by 126 · see citing works

Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.

Cichewicz, D. L., Martin, Z. L., Smith, F. L., & Welch, S. P. (1999) · PubMed · Cited by 121 · see citing works

Cannabinoid receptor homo- and heterodimerization

Mackie, K. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.011 · Cited by 119 · see citing works

Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors

Milligan, G. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.11.010 · Cited by 119 · see citing works

Allosteric coupling between morphine and enkephalin receptors in vitro.

Rothman, R. B., & Westfall, T. C. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14920-1 · Cited by 118 · see citing works

A Bivalent Ligand (KDAN-18) Containing δ-Antagonist and κ-Agonist Pharmacophores Bridges δ2 and κ1 Opioid Receptor Phenotypes

Daniels, D. J., Kulkarni, A. A., Xie, Z., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm034234f · Cited by 117 · see citing works

A day in the life of a G protein‐coupled receptor: the contribution to function of G protein‐coupled receptor dimerization

Milligan, G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707490 · Cited by 114 · see citing works

Heterodimerization of μ- and δ-Opioid Receptors Occurs at the Cell Surface Only and Requires Receptor-G Protein Interactions

Law, P., Erickson, L. J., Zha, Q., Solberg, J., Chu, J., Sarre, A., & Loh, H. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500171200 · Cited by 113 · see citing works

Dimeric tetrapeptide enkephalins display extraordinary selectivity for the δ opiate receptor

Shimohigashi, Y., Costa, T., Chen, H., & Rodbard, D. (1982) · Nature · doi:10.1038/297333a0 · Cited by 113 · see citing works

Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction

Nieto, M. M., Pommier, B., Tzavara, E. T., Caneparo, A., Nascimento, S. D., Fur, G. L., Roques, B. P., & Noble, F. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703990 · Cited by 111 · see citing works

Cannabinoid Action Depends on Phosphorylation of Dopamine- and cAMP-Regulated Phosphoprotein of 32 kDa at the Protein Kinase A Site in Striatal Projection Neurons

Andersson, M., Usiello, A., Borgkvist, A., Pozzi, L., Dominguez, C. A., Fienberg, A. A., Svenningsson, P., Fredholm, B. B., Borrelli, E., Greengard, P., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1289-05.2005 · Cited by 110 · see citing works

Modulation of Oral Morphine Antinociceptive Tolerance and Naloxone-Precipitated Withdrawal Signs by Oral Δ9-Tetrahydrocannabinol

Cichewicz, D. L., & Welch, S. P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046870 · Cited by 110 · see citing works

The μ Opioid Agonist Morphine Modulates Potentiation of Capsaicin-Evoked TRPV1 Responses through a Cyclic AMP-Dependent Protein Kinase a Pathway

Vetter, I., Wyse, B. D., Monteith, G. R., et al. (2006) · Molecular Pain · doi:10.1186/1744-8069-2-22 · Cited by 106 · see citing works

Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine

Roberts, J. D., Gennings, C., & Shih, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.11.036 · Cited by 103 · see citing works

IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data

Sharman, J. L., Mpamhanga, C. P., Spedding, M., Germain, P., Staels, B., Dacquet, C., Laudet, V., Harmar, A. J., & NC-IUPHAR (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1062 · Cited by 102 · see citing works

The CB1 Cannabinoid Receptor Juxtamembrane C-Terminal Peptide Confers Activation to Specific G proteins in Brain

Mukhopadhyay, S., McIntosh, H. H., Houston, D. B., & Howlett, A. C. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26454-3 · Cited by 101 · see citing works

Antisense Oligodeoxynucleotides to Opioid Mu and Delta Receptors Reduced Morphine Dependence in Mice: Role of Delta-2 Opioid Receptors

Sánchez‐Blázquez, P., García‐España, A., & Garzón, J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36506-1 · Cited by 97 · see citing works

Morphine allosterically modulates the binding of [3H]leucine enkephalin to a particulate fraction of rat brain.

Rothman, R. B., & Westfall, T. C. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14934-1 · Cited by 94 · see citing works

Characterization of cannabinoid-1 receptors in the locus coeruleus: Relationship with mu-opioid receptors

Scavone, J. L., Mackie, K., & Bockstaele, E. J. V. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.023 · Cited by 92 · see citing works

Trafficking of Preassembled Opioid μ−δ Heterooligomer−Gz Signaling Complexes to the Plasma Membrane: Coregulation by Agonists

Hasbi, A., Nguyen, T., Fan, T., et al. (2007) · Biochemistry · doi:10.1021/bi701436w · Cited by 90 · see citing works

Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores

Lenard, N. R., Daniels, D. J., Portoghese, P. S., & Roerig, S. C. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.040 · Cited by 82 · see citing works

Membrane-Delimited Coupling of TRPV1 and mGluR5 on Presynaptic Terminals of Nociceptive Neurons

Kim, Y. H., Park, C., Back, S. K., Lee, C. J., Hwang, S. J., Bae, Y. C., Na, H. S., Kim, J. S., Jung, S. J., & Oh, S. B. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5030-08.2009 · Cited by 80 · see citing works

GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base

Khelashvili, G., Dorff, K. C., Shan, J., Camacho‐Artacho, M., Skrabanek, L. A., Vroling, B., Bouvier, M., Devi, L. A., George, S. R., Javitch, J. A., et al. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq264 · Cited by 80 · see citing works

Opioid agonist and antagonist bivalent ligands as receptor probes

Portoghese, P. S., Ronsisvalle, G., Larson, D. L., Yim, C. B., Sayre, L. M., & Takemori, A. E. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90362-9 · Cited by 79 · see citing works

Heterodimerization of opioid receptor‐like 1 and µ‐opioid receptors impairs the potency of µ receptor agonist

Wang, H., Hsu, C., Huang, P., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02921.x · Cited by 73 · see citing works

N -naphthoyl-β-naltrexamine (NNTA), a highly selective and potent activator of μ/κ-opioid heteromers

Yekkirala, A. S., Lunzer, M. M., McCurdy, C. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016277108 · Cited by 68 · see citing works

Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice

Castañé, A., Robledo, P., Matifas, A., Kieffer, B. L., & Maldonado, R. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02409.x · Cited by 67 · see citing works

A role for central cannabinoid and opioid systems in peripheral Δ9-tetrahydrocannabinol-induced analgesia in mice

Reche, I., Fuentes, J. A., & Ruiz‐Gayo, M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00045-3 · Cited by 64 · see citing works

Induced Association of μ Opioid (MOP) and Type 2 Cholecystokinin (CCK2) Receptors by Novel Bivalent Ligands

Zheng, Y., Akgün, E., Harikumar, K. G., Hopson, J. A., Powers, M. D., Lunzer, M. M., Miller, L. J., & Portoghese, P. S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800174p · Cited by 60 · see citing works

Enhancement of μ Opioid Antinociception by Oral Δ9-Tetrahydrocannabinol: Dose-Response Analysis and Receptor Identification

Cichewicz, D. L., Martin, Z. L., Smith, F. L., & Welch, S. P. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38212-6 · Cited by 60 · see citing works

Standard Opioid Agonists Activate Heteromeric Opioid Receptors: Evidence for Morphine and [ d -Ala2-MePhe4-Glyol5]Enkephalin as Selective μ−δ Agonists

Yekkirala, A. S., Kalyuzhny, A. E., & Portoghese, P. S. (2009) · ACS Chemical Neuroscience · doi:10.1021/cn9000236 · Cited by 57 · see citing works

Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the μ-opioid receptor

Schröder, H., Wu, D.-F., Seifert, A., Rankovic, M., Schulz, S., Höllt, V., & Koch, T. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.12.010 · Cited by 57 · see citing works

Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors

Portoghese, P. S., Larson, D. L., Yim, C. B., et al. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00147a002 · Cited by 56 · see citing works

Increased biological activity of dimers of oxymorphone and enkephalin: Possible role of receptor crosslinking

Hazum, E., Chang, K., Leighton, H. J., Lever, O. W., & Cuatrecasas, P. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91981-7 · Cited by 52 · see citing works

TENA, a selective kappa opioid receptor antagonist

Portoghese, P. S., & Takemori, A. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90202-4 · Cited by 48 · see citing works

Oligomerization of the α and β isoforms of the thromboxane A2 receptor: Relevance to receptor signaling and endocytosis

Laroche, G., Lépine, M., Thériault, C., et al. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.02.008 · Cited by 47 · see citing works

Computational studies of Family A and Family B GPCRs

Vohra, S., Chintapalli, S. V., Illingworth, C. J. R., Reeves, P. J., Mullineaux, P. M., Clark, H. S. X., Dean, M. K., UPTON, G. J. G., & Reynolds, C. A. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350749 · Cited by 45 · see citing works

INTERACTIONS BETWEEN δ OPIOID RECEPTORS AND α2A‐ADRENOCEPTORS

Rios, C., Gomes, I., & Devi, L. A. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.04076.x · Cited by 38 · see citing works

Receptor binding and biological activity of bivalent enkephalins

Costa, T., Wüster, M., Herz, A., et al. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90095-4 · Cited by 37 · see citing works

The Composition of the β-2 Adrenergic Receptor Oligomer Affects Its Membrane Trafficking after Ligand-Induced Endocytosis

Cao, T. T., Brelot, A., & von Zastrow, M. E. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.003608 · Cited by 34 · see citing works

Coexistence of kappa- and delta-opioid receptors in rat spinal cord axons

Wessendorf, M. W., & Dooyema, J. M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01700-6 · Cited by 33 · see citing works

Leucine enkephalin noncompetitively inhibits the binding of [3H]naloxone to the opiate mu-recognition site: Evidence for delta←mu binding site interactions in vitro

Rothman, R. B., Danks, J. A., Jacobson, A. E., et al. (1985) · Neuropeptides · doi:10.1016/0143-4179(85)90008-3 · Cited by 32 · see citing works

Dimeric pentapeptide enkephalin: A novel probe of delta opiate receptors

Costa, T., Shimohigashi, Y., Krumins, S. A., Munson, P. J., & Rodbard, D. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90055-8 · Cited by 29 · see citing works

Hetero-oligomers of α2A-adrenergic and μ-opioid receptors do not lead to transactivation of G-proteins or altered endocytosis profiles

Zhang, Y. Q., & Limbird, L. E. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320856 · Cited by 29 · see citing works

Homodimerization of Human Mu-Opoid Receptor Overexpressed in Sf9 Insect Cells

Chen, L., Gao, C., De-He, Z., et al. (2002) · Protein and Peptide Letters · doi:10.2174/0929866023408850 · Cited by 15 · see citing works

Binding to opioid receptors of enkephalin derivatives taking α‐helical conformation and its dimer

SASAKI‐YAGI, Y., Kimura, S., & Imanishi, Y. (1991) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1991.tb01517.x · Cited by 9 · see citing works

G protein-coupled receptors function as cell membrane receptors for the steroid hormone 20-hydroxyecdysone

Zhao, X.-F. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00620-y · Cited by 60 · see citing works

From Atomic Structures to Neuronal Functions of G Protein–Coupled Receptors

Palczewski, K., & Orban, T. (2013) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062012-170313 · Cited by 44 · see citing works

G-protein-coupled receptor participates in 20-hydroxyecdysone signaling on the plasma membrane

Cai, M.-J., Dong, D.-J., Wang, Y., Liu, P.-C., Liu, W., Wang, J.-X., & Zhao, X.-F. (2014) · Cell Communication and Signaling · doi:10.1186/1478-811x-12-9 · Cited by 44 · see citing works

Cannabinoid Ligand-Receptor Signaling During Early Pregnancy in the Mouse

Paria, B. C., Das, S., & Dey, S. K. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_40 · Cited by 3 · see citing works

Pharmacological characterization of the cannabinoid CB1 receptor PET ligand ortholog, [3H]MePPEP

Suter, T. M., Chesterfield, A. K., Bao, C., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.08.055 · Cited by 6 · see citing works

Cannabinoid–improgan cross-tolerance: Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid CB1 receptor

Nalwalk, J. W., Svokos, K. A., & Hough, L. B. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.035 · Cited by 9 · see citing works

Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes

Wiley, J. L., & Martin, B. R. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00146-9 · Cited by 100 · see citing works

Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles

Jansen, E. M., Haycock, D. A., Ward, S. J., & Seybold, V. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)90428-c · Cited by 140 · see citing works